All Stories

  1. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell

    Article • European Respiratory Review, May 2022, European Respiratory Society (ERS)

    Nathan Bartlett

  2. TLR2-mediated innate immune priming boosts lung anti-viral immunity

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark, Nathan Bartlett, Dr Punnam Chander Veerati